Andy Tran
Biotech Investor, Matrix Capital Management, Board Director @ GentiBio
About Andy Tran
Andy Tran is a biotech investor at Matrix Capital Management and serves as a board director.
Known information
Andy Tran holds a prominent position in the biotech industry as an investor with Matrix Capital Management. In addition to his role in investment, he contributes to strategic decision-making as a board director. His involvement in Matrix Capital Management allows him to play a significant role in shaping the future of biotechnology investments, leveraging his expertise to guide the company’s investment strategies and governance.
About GentiBio
GentiBio is a biotech company focused on developing engineered T regulatory cell therapies for various immune and inflammatory diseases, with its lead product GNTI-122 targeting type 1 diabetes.